J&J Halts Covid-19 Vaccine Trial Due to Unexplained Illness
Bloomberg News
October 12, 2020, 8:58 PM EDT
Updated on October 13, 2020, 4:13 AM EDT
Johnson & Johnson halted clinical trials of its Covid-19 vaccine after a participant fell ill, the second time that a front-runner developer has paused testing in the race to create a viable immunization against the virus.
The participant’s illness is being evaluated, the New Brunswick, New Jersey-based company said late Monday, adding that it would share information after further investigation. J&J shares fell 2.4% in trading before U.S. exchanges opened. The vaccine is undergoing tests in as many as 60,000 volunteers from Peru to South Africa.............
https://www.bloomberg.com/amp/news/artic...ding_now_1
Bloomberg News
October 12, 2020, 8:58 PM EDT
Updated on October 13, 2020, 4:13 AM EDT
Johnson & Johnson halted clinical trials of its Covid-19 vaccine after a participant fell ill, the second time that a front-runner developer has paused testing in the race to create a viable immunization against the virus.
The participant’s illness is being evaluated, the New Brunswick, New Jersey-based company said late Monday, adding that it would share information after further investigation. J&J shares fell 2.4% in trading before U.S. exchanges opened. The vaccine is undergoing tests in as many as 60,000 volunteers from Peru to South Africa.............
https://www.bloomberg.com/amp/news/artic...ding_now_1
__________________